Your Partner in Scientific Discovery
We Provide Comprehensive Support for Clinical Trials from Start to Finish
VeraSci is not just there in the beginning; we take care of your study objectives and data throughout the entire trial. Our team has unparalleled experience in clinical outcomes and neurocognitive measurement and a proven track record in supporting trial design, implementation, and evaluation.
Performance-Based Site Identification
VeraSci works with sponsors to identify sites with the right experience, the right raters, the right capabilities based on historical performance, all to deliver high-quality data. Focusing on sites with low placebo response rates and high enrollment can help get trials off to a strong start. We provide additional guidance to ensure that trials are equipped with the best sites to meet their needs.
Rater Training and Certification
Study engagement, data quality, and site performance all start with rater training. Developed by experienced clinicians with input from seasoned site raters, our training incorporates useful strategies to overcome challenges in test administration. We have trained and certified raters around the world to administer a wide variety of neuropsychological assessments in therapeutic areas ranging from major depression to dementia to schizophrenia.VeraSci provides differentiated training based on experience and expertise. We train raters individually and require raters to demonstrate the required skills to administer assessments in an unbiased and expert manner before they ever screen a patient.
Data Quality Assurance
Conclusive signal detection depends on high-quality data collection. Our expert reviewers identify administration inconsistencies and provide central scoring for a wide range of clinical and cognitive assessments, with rapid turnaround that ensures a clean dataset in real-time. This helps sites save time, stay engaged, and stay informed about study-specific assessment procedures. VeraSci data reviewers and the scientific team are valuable resources to investigators and site raters throughout a clinical trial.
Our Data Services include:
- Study-specific data monitoring and reporting plan that achieves the highest-level or data quality with the most efficient use of resources
- Expert data review and centralized monitoring that have been proven to help reduce test administration and scoring errors, resulting in enhanced reliability
- Remote review and monitoring of study data, along with interview audio recordings, via our web-based data portal
- Statistical analysis by our in-house biostatisticians to assist with interpretation of your data
- Study-specific data transfers in SDTM format following CDISC guidelines for all scales
Clinical Video Surveillance and Recording
VeraSci offers state-of-the-art technology for recording clinical and cognitive testing sessions, which ensures standardized test administration across multiple sites and raters.
Benefits of Clinical Trial Video Recording and Surveillance:
- Fraud Identification
- Enhanced data quality and signal detection
- Secured source encryption technology for end-to-end data protection
- 24/7 Help Desk support
Powered by Advanced Visuals, Inc.
Enrolling the correct subjects is critical for clinical trial sucess. Ineligible subjects create serious risk of study failure because those with co-morbid indications and safety concerns can cloud the efficacy signal. Even well-written protocols require PIs to assess dozens of inclusion/exclusion criteria, lists of prohibited medications and qualifying biomarkers, in a busy clinic environment. Particularly when diagnostic and entry assessments are complex and subjective, ineligible subjects can enter a trial and create unwanted variance that threatens the trial’s integrity.
VeraSci’s eligibility review service protects the adherence to inclusion and exclusion criteria and reduces safety risk by having a medical scientist and clinical scientist meticulously examine each subject’s medical profile. VeraSci customizes the eligibility review to each protocol, tailoring the focus on the specific indication, entry scales, qualifying biomarker features, and IP characteristics. Protecting the trial at this earliest stage of enrollment decreases clinical trial costs while ensuring the highest quality trial data.